Destination Innovation: 11AM – 12PM

destinnovation

Shapiro Breakout Room | 11AM – 12PM

Brigham and Women’s Hospital has always been a leader in innovation. We have been fortunate to have nurtured many breakthroughs and discoveries over the years—from conducting the first kidney transplant and first face transplant—transforming the current healthcare process. But where do innovative solutions come from and how can innovation help us to fulfill our core mission: to provide the best possible care to our patients? In this session, BWH experts will discuss the ideation process and the impact of innovative research and technology on patient care.

Introduction on the Ideation Process

Frederick J. Schoen, MD, PhD
Director, Technology and Innovation Program, BWH Biomedical Research Institute Executive Vice Chairman, Department of Pathology, Brigham and Women’s Hospital; Professor of Pathology and Health Sciences and Technology (HST), Harvard Medical School

Idea Concept & Brainstorming

Ali Tavakkoli, MD

Early Stage Research

Timothy Heinrich

Nanotechnology

Jinjun Shi

Use of AMIGO Technology

Alexandra J. Golby, MD

Global Health

Utkan Demirci, PhD

Conclusion

Christopher Coburn

 


 

Speakers

Alexandra J. Golby, MD

Alexandra J. Golby is Associate Professor of Surgery and Radiology, Harvard Medical School, and an expert in pre-operative functional and diffusion MRI, image-guided surgical navigation, and clinical translational neuroscience. She is director of Image-Guided Neurosurgery at Brigham & Women’s Hospital, as well as director of the National Center for Image-Guided Therapy Neurosurgery Core, and clinical co-director of the Advanced Multimodality Image-Guided OR. She completed her M.D., junior residency, and NIH National Research Service Award Post-doctoral fellowship (2001) at Stanford University, and was Chief Resident in Neurosurgery (2002) at Brigham and Women’s Hospital.  Her lab brings together experts in imaging, image processing, and brain mapping to develop and validate improved surgical approaches for patients with brain tumors and epilepsy.

 

Ali Tavakkoli, MD
Co-Director, Center for Weight Management and Metabolic Surgery, Minimally Invasive and GI Surgery, Brigham and Women’s Hospital, Assistant Professor of Surgery, Harvard Medical School

Dr. Tavakkoli is a minimally invasive surgeon and researcher at Brigham and Women’s Hospital. His research lab’s main focus is on the function of the intestine and novel approaches to treating diseases such as obesity and diabetes.  He also leads iTEAM, a working group of clinical residents and engineers with the goal of improving care through device and process innovation.

 


 

Session Co-Chairs

Adam LandmanAdam Landman, MD, MS, MIS, MHS
Associate Physician, Department of Emergency Medicine

Adam Landman, MD, MS, MIS, MHS, is an emergency physician and CMIO for Health Information Innovation & Integration at BWH.  He is helping lead the implementation and integration of a new hospital laboratory system as well as multiple projects related to a new enterprise electronic health record implementation.  He also leads health information innovation programs focused on applying health information technology to improve health care delivery.

 

KarpJeff Karp, PhD
Associate Professor of Medicine

Jeff Karp’s research uses nano/microscale materials and bioinspired biology to solve medical problems. Tissue adhesives that he developed were selected as one of Popular Mechanic’s “Top 20 New Biotech Breakthroughs that Will Change Medicine” and he has invented several technologies that have been internationally recognized including a new neonatal adhesive that can be quickly removed without damage, inflammation responsive materials for treatment of proteolytic disease, nanosensors that can be used to visualize cell-cell communication in real-time, and a nanoparticle prophylactic approach to prevent contact dermatitis. He is also a leading authority on mesenchymal stem cell therapy.

 

 

DSCF0030 Schoen 2 x 2.5 cropped head only

Frederick J. Schoen, MD, PhD
Director, Technology and Innovation Program, BWH Biomedical Research Institute Executive Vice Chairman, Department of Pathology, Brigham and Women’s Hospital; Professor of Pathology and Health Sciences and Technology (HST), Harvard Medical School

Frederick J. Schoen is Director of the BWH Biomedical Research Institute (BRI) Technology and Innovation Initiative and BWH liaison to (Site Miner for) the Center for Integration of Medicine and Innovative Technology (CIMIT). He is also Professor of Pathology and Health Sciences and Technology, Harvard Medical School and Executive Vice-Chairman in the Department of Pathology at BWH. Schoen has leadership responsibilities in academic programs in the Department of Pathology, Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology (HST) and is an active teacher/director of courses in pathology, cardiovascular pathology, biomaterials, tissue engineering, and medical device development at Harvard, MIT and the Harvard Catalyst. Dr. Schoen’s research is in cardiovascular pathology, heart valve substitutes, biomaterials and tissue engineering. His activities entail considerable interaction with industry, technology transfer, venture capital and regulatory scientists and other non-academic personnel related to the furthering and translation of biomedical science. Schoen earned a Ph.D. in Materials Science from Cornell University (1970) and an M.D. from the University of Miami School of Medicine (1974). Following a Surgery internship, residency in Anatomic Pathology and fellowship in Thoracic and Cardiovascular Pathology, he joined BWH and Harvard Medical School in 1980.